TREACE MEDICAL CONCEPTS INC. - COMMON STOCK

Treace to Report Second Quarter 2023 Financial Results on August 8, 2023

18 Jul 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer

12 Jul 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System

13 Jun 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries

01 Jun 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Reports First Quarter 2023 Financial Results

08 May 2023 15:05:01 By Nasdaq GlobeNewswire

Treace Announces Participation in the Bank of America 2023 Healthcare Conference

26 Apr 2023 15:15:00 By Nasdaq GlobeNewswire

Treace to Report First Quarter 2023 Financial Results on May 8, 2023

20 Apr 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities

19 Apr 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Publishes Inaugural ESG Report

04 Apr 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results

07 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics

03 Mar 2023 08:03:20 By Nasdaq GlobeNewswire

Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

27 Feb 2023 15:15:00 By Nasdaq GlobeNewswire

Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference

09 Feb 2023 12:00:00 By Nasdaq GlobeNewswire

Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock

07 Feb 2023 20:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock

07 Feb 2023 15:30:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue

09 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

20 Dec 2022 15:15:00 By Nasdaq GlobeNewswire

Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents

19 Dec 2022 15:15:00 By Nasdaq GlobeNewswire

Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology

28 Nov 2022 15:15:00 By Nasdaq GlobeNewswire

Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study

21 Nov 2022 15:15:00 By Nasdaq GlobeNewswire